Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor

We report a case of rhabdoid tumor predisposition syndrome with a renal tumor developing 10 years after a brain tumor, which demonstrated an unexpectedly favorable outcome. A 2‐year‐old boy underwent gross total resection of a brain tumor located in the fourth ventricle, and received adjuvant chemot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathology international 2021-02, Vol.71 (2), p.155-160
Hauptverfasser: Fukushima, Hiroko, Yamasaki, Kai, Sakaida, Miho, Tsujio, Nozomi, Okuno, Takahiro, Ishii, Naomi, Okada, Keiko, Fujisaki, Hiroyuki, Matsusaka, Yasuhiro, Sakamoto, Hiroaki, Yoneda, Akihiro, Hara, Junichi, Inoue, Takeshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 160
container_issue 2
container_start_page 155
container_title Pathology international
container_volume 71
creator Fukushima, Hiroko
Yamasaki, Kai
Sakaida, Miho
Tsujio, Nozomi
Okuno, Takahiro
Ishii, Naomi
Okada, Keiko
Fujisaki, Hiroyuki
Matsusaka, Yasuhiro
Sakamoto, Hiroaki
Yoneda, Akihiro
Hara, Junichi
Inoue, Takeshi
description We report a case of rhabdoid tumor predisposition syndrome with a renal tumor developing 10 years after a brain tumor, which demonstrated an unexpectedly favorable outcome. A 2‐year‐old boy underwent gross total resection of a brain tumor located in the fourth ventricle, and received adjuvant chemotherapy and radiotherapy. At the age of 11 years, a renal tumor was found and nephrectomy was performed. He is currently alive without evidence of disease over 2 years without postoperative therapy. Histologically, rhabdoid cells were observed in both brain and renal tumors. Loss of SMARCB1 (also known as INI1) expression was found in the nucleus of both tumor cells. Genetic testing revealed pathogenic variants of SMARCB1 exon 5 in the renal tumor and SMARCB1 exon 9 in the brain tumor. In addition, heterozygous deletion of 22q11.21‐q11.23 containing the SMARCB1 locus was shared by both tumors and this deletion was identified in normal peripheral blood. Considering the histopathological and genetic findings, our case was considered to be rhabdoid tumor predisposition syndrome with atypical teratoid/rhabdoid tumor and late‐onset rhabdoid tumor of the kidney.
doi_str_mv 10.1111/pin.13056
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2488006679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2488006679</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3446-38b3347332cf43bef2b7cb208b3f78d0b274c3a3ec048fc63ce75447dd5d092b3</originalsourceid><addsrcrecordid>eNp1kE1Lw0AQhhdRbK0e_AOy4MlD2s3OJrs9SvGjUFSKnsN-hW5psnE3peTfG0315lxmmHl4GF6ErlMyTfuaNa6epkCy_ASNU8ZIkgrKT_sZKEkylsMIXcS4JSTlkJNzNAIALjKRj9F6vZHKeGdwu698wE2wxsXGR9c6X-PY1Sb4yuKDazc42FrujmBKcGdliFiWrQ1YBenq4XSJzkq5i_bq2Cfo4_HhffGcrF6flov7VaKBsTwBoQAYB6C6ZKBsSRXXipJ-XXJhiKKcaZBgNWGi1DloyzPGuDGZIXOqYIJuB28T_OfexrbY-n3oP4wFZUIQkud83lN3A6WDjzHYsmiCq2ToipQU3-kVfXrFT3o9e3M07lVlzR_5G1cPzAbg4Ha2-99UvC1fBuUXV4t5Hg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2488006679</pqid></control><display><type>article</type><title>Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor</title><source>Wiley Online Library All Journals</source><creator>Fukushima, Hiroko ; Yamasaki, Kai ; Sakaida, Miho ; Tsujio, Nozomi ; Okuno, Takahiro ; Ishii, Naomi ; Okada, Keiko ; Fujisaki, Hiroyuki ; Matsusaka, Yasuhiro ; Sakamoto, Hiroaki ; Yoneda, Akihiro ; Hara, Junichi ; Inoue, Takeshi</creator><creatorcontrib>Fukushima, Hiroko ; Yamasaki, Kai ; Sakaida, Miho ; Tsujio, Nozomi ; Okuno, Takahiro ; Ishii, Naomi ; Okada, Keiko ; Fujisaki, Hiroyuki ; Matsusaka, Yasuhiro ; Sakamoto, Hiroaki ; Yoneda, Akihiro ; Hara, Junichi ; Inoue, Takeshi</creatorcontrib><description>We report a case of rhabdoid tumor predisposition syndrome with a renal tumor developing 10 years after a brain tumor, which demonstrated an unexpectedly favorable outcome. A 2‐year‐old boy underwent gross total resection of a brain tumor located in the fourth ventricle, and received adjuvant chemotherapy and radiotherapy. At the age of 11 years, a renal tumor was found and nephrectomy was performed. He is currently alive without evidence of disease over 2 years without postoperative therapy. Histologically, rhabdoid cells were observed in both brain and renal tumors. Loss of SMARCB1 (also known as INI1) expression was found in the nucleus of both tumor cells. Genetic testing revealed pathogenic variants of SMARCB1 exon 5 in the renal tumor and SMARCB1 exon 9 in the brain tumor. In addition, heterozygous deletion of 22q11.21‐q11.23 containing the SMARCB1 locus was shared by both tumors and this deletion was identified in normal peripheral blood. Considering the histopathological and genetic findings, our case was considered to be rhabdoid tumor predisposition syndrome with atypical teratoid/rhabdoid tumor and late‐onset rhabdoid tumor of the kidney.</description><identifier>ISSN: 1320-5463</identifier><identifier>EISSN: 1440-1827</identifier><identifier>DOI: 10.1111/pin.13056</identifier><identifier>PMID: 33378586</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>atypical teratoid/rhabdoid tumor (AT/RT) ; Brain ; Brain cancer ; Brain tumors ; Case reports ; Chemotherapy ; favorable outcome ; Gene deletion ; Genetic screening ; Kidneys ; late onset ; Nephrectomy ; Peripheral blood ; Radiation therapy ; rhabdoid tumor of the kidney (RTK) ; rhabdoid tumor predisposition syndrome (RTPS) ; SMARCB1 ; Tumor cells ; Tumors ; Ventricle ; Ventricles (cerebral)</subject><ispartof>Pathology international, 2021-02, Vol.71 (2), p.155-160</ispartof><rights>2020 Japanese Society of Pathology and John Wiley &amp; Sons Australia, Ltd</rights><rights>2020 Japanese Society of Pathology and John Wiley &amp; Sons Australia, Ltd.</rights><rights>2021 Japanese Society of Pathology and John Wiley &amp; Sons Australia, Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3446-38b3347332cf43bef2b7cb208b3f78d0b274c3a3ec048fc63ce75447dd5d092b3</citedby><cites>FETCH-LOGICAL-c3446-38b3347332cf43bef2b7cb208b3f78d0b274c3a3ec048fc63ce75447dd5d092b3</cites><orcidid>0000-0001-9206-6696 ; 0000-0002-0985-1501 ; 0000-0002-5701-8813</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpin.13056$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpin.13056$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33378586$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fukushima, Hiroko</creatorcontrib><creatorcontrib>Yamasaki, Kai</creatorcontrib><creatorcontrib>Sakaida, Miho</creatorcontrib><creatorcontrib>Tsujio, Nozomi</creatorcontrib><creatorcontrib>Okuno, Takahiro</creatorcontrib><creatorcontrib>Ishii, Naomi</creatorcontrib><creatorcontrib>Okada, Keiko</creatorcontrib><creatorcontrib>Fujisaki, Hiroyuki</creatorcontrib><creatorcontrib>Matsusaka, Yasuhiro</creatorcontrib><creatorcontrib>Sakamoto, Hiroaki</creatorcontrib><creatorcontrib>Yoneda, Akihiro</creatorcontrib><creatorcontrib>Hara, Junichi</creatorcontrib><creatorcontrib>Inoue, Takeshi</creatorcontrib><title>Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor</title><title>Pathology international</title><addtitle>Pathol Int</addtitle><description>We report a case of rhabdoid tumor predisposition syndrome with a renal tumor developing 10 years after a brain tumor, which demonstrated an unexpectedly favorable outcome. A 2‐year‐old boy underwent gross total resection of a brain tumor located in the fourth ventricle, and received adjuvant chemotherapy and radiotherapy. At the age of 11 years, a renal tumor was found and nephrectomy was performed. He is currently alive without evidence of disease over 2 years without postoperative therapy. Histologically, rhabdoid cells were observed in both brain and renal tumors. Loss of SMARCB1 (also known as INI1) expression was found in the nucleus of both tumor cells. Genetic testing revealed pathogenic variants of SMARCB1 exon 5 in the renal tumor and SMARCB1 exon 9 in the brain tumor. In addition, heterozygous deletion of 22q11.21‐q11.23 containing the SMARCB1 locus was shared by both tumors and this deletion was identified in normal peripheral blood. Considering the histopathological and genetic findings, our case was considered to be rhabdoid tumor predisposition syndrome with atypical teratoid/rhabdoid tumor and late‐onset rhabdoid tumor of the kidney.</description><subject>atypical teratoid/rhabdoid tumor (AT/RT)</subject><subject>Brain</subject><subject>Brain cancer</subject><subject>Brain tumors</subject><subject>Case reports</subject><subject>Chemotherapy</subject><subject>favorable outcome</subject><subject>Gene deletion</subject><subject>Genetic screening</subject><subject>Kidneys</subject><subject>late onset</subject><subject>Nephrectomy</subject><subject>Peripheral blood</subject><subject>Radiation therapy</subject><subject>rhabdoid tumor of the kidney (RTK)</subject><subject>rhabdoid tumor predisposition syndrome (RTPS)</subject><subject>SMARCB1</subject><subject>Tumor cells</subject><subject>Tumors</subject><subject>Ventricle</subject><subject>Ventricles (cerebral)</subject><issn>1320-5463</issn><issn>1440-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kE1Lw0AQhhdRbK0e_AOy4MlD2s3OJrs9SvGjUFSKnsN-hW5psnE3peTfG0315lxmmHl4GF6ErlMyTfuaNa6epkCy_ASNU8ZIkgrKT_sZKEkylsMIXcS4JSTlkJNzNAIALjKRj9F6vZHKeGdwu698wE2wxsXGR9c6X-PY1Sb4yuKDazc42FrujmBKcGdliFiWrQ1YBenq4XSJzkq5i_bq2Cfo4_HhffGcrF6flov7VaKBsTwBoQAYB6C6ZKBsSRXXipJ-XXJhiKKcaZBgNWGi1DloyzPGuDGZIXOqYIJuB28T_OfexrbY-n3oP4wFZUIQkud83lN3A6WDjzHYsmiCq2ToipQU3-kVfXrFT3o9e3M07lVlzR_5G1cPzAbg4Ha2-99UvC1fBuUXV4t5Hg</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Fukushima, Hiroko</creator><creator>Yamasaki, Kai</creator><creator>Sakaida, Miho</creator><creator>Tsujio, Nozomi</creator><creator>Okuno, Takahiro</creator><creator>Ishii, Naomi</creator><creator>Okada, Keiko</creator><creator>Fujisaki, Hiroyuki</creator><creator>Matsusaka, Yasuhiro</creator><creator>Sakamoto, Hiroaki</creator><creator>Yoneda, Akihiro</creator><creator>Hara, Junichi</creator><creator>Inoue, Takeshi</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0001-9206-6696</orcidid><orcidid>https://orcid.org/0000-0002-0985-1501</orcidid><orcidid>https://orcid.org/0000-0002-5701-8813</orcidid></search><sort><creationdate>202102</creationdate><title>Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor</title><author>Fukushima, Hiroko ; Yamasaki, Kai ; Sakaida, Miho ; Tsujio, Nozomi ; Okuno, Takahiro ; Ishii, Naomi ; Okada, Keiko ; Fujisaki, Hiroyuki ; Matsusaka, Yasuhiro ; Sakamoto, Hiroaki ; Yoneda, Akihiro ; Hara, Junichi ; Inoue, Takeshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3446-38b3347332cf43bef2b7cb208b3f78d0b274c3a3ec048fc63ce75447dd5d092b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>atypical teratoid/rhabdoid tumor (AT/RT)</topic><topic>Brain</topic><topic>Brain cancer</topic><topic>Brain tumors</topic><topic>Case reports</topic><topic>Chemotherapy</topic><topic>favorable outcome</topic><topic>Gene deletion</topic><topic>Genetic screening</topic><topic>Kidneys</topic><topic>late onset</topic><topic>Nephrectomy</topic><topic>Peripheral blood</topic><topic>Radiation therapy</topic><topic>rhabdoid tumor of the kidney (RTK)</topic><topic>rhabdoid tumor predisposition syndrome (RTPS)</topic><topic>SMARCB1</topic><topic>Tumor cells</topic><topic>Tumors</topic><topic>Ventricle</topic><topic>Ventricles (cerebral)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fukushima, Hiroko</creatorcontrib><creatorcontrib>Yamasaki, Kai</creatorcontrib><creatorcontrib>Sakaida, Miho</creatorcontrib><creatorcontrib>Tsujio, Nozomi</creatorcontrib><creatorcontrib>Okuno, Takahiro</creatorcontrib><creatorcontrib>Ishii, Naomi</creatorcontrib><creatorcontrib>Okada, Keiko</creatorcontrib><creatorcontrib>Fujisaki, Hiroyuki</creatorcontrib><creatorcontrib>Matsusaka, Yasuhiro</creatorcontrib><creatorcontrib>Sakamoto, Hiroaki</creatorcontrib><creatorcontrib>Yoneda, Akihiro</creatorcontrib><creatorcontrib>Hara, Junichi</creatorcontrib><creatorcontrib>Inoue, Takeshi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Pathology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fukushima, Hiroko</au><au>Yamasaki, Kai</au><au>Sakaida, Miho</au><au>Tsujio, Nozomi</au><au>Okuno, Takahiro</au><au>Ishii, Naomi</au><au>Okada, Keiko</au><au>Fujisaki, Hiroyuki</au><au>Matsusaka, Yasuhiro</au><au>Sakamoto, Hiroaki</au><au>Yoneda, Akihiro</au><au>Hara, Junichi</au><au>Inoue, Takeshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor</atitle><jtitle>Pathology international</jtitle><addtitle>Pathol Int</addtitle><date>2021-02</date><risdate>2021</risdate><volume>71</volume><issue>2</issue><spage>155</spage><epage>160</epage><pages>155-160</pages><issn>1320-5463</issn><eissn>1440-1827</eissn><abstract>We report a case of rhabdoid tumor predisposition syndrome with a renal tumor developing 10 years after a brain tumor, which demonstrated an unexpectedly favorable outcome. A 2‐year‐old boy underwent gross total resection of a brain tumor located in the fourth ventricle, and received adjuvant chemotherapy and radiotherapy. At the age of 11 years, a renal tumor was found and nephrectomy was performed. He is currently alive without evidence of disease over 2 years without postoperative therapy. Histologically, rhabdoid cells were observed in both brain and renal tumors. Loss of SMARCB1 (also known as INI1) expression was found in the nucleus of both tumor cells. Genetic testing revealed pathogenic variants of SMARCB1 exon 5 in the renal tumor and SMARCB1 exon 9 in the brain tumor. In addition, heterozygous deletion of 22q11.21‐q11.23 containing the SMARCB1 locus was shared by both tumors and this deletion was identified in normal peripheral blood. Considering the histopathological and genetic findings, our case was considered to be rhabdoid tumor predisposition syndrome with atypical teratoid/rhabdoid tumor and late‐onset rhabdoid tumor of the kidney.</abstract><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33378586</pmid><doi>10.1111/pin.13056</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9206-6696</orcidid><orcidid>https://orcid.org/0000-0002-0985-1501</orcidid><orcidid>https://orcid.org/0000-0002-5701-8813</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1320-5463
ispartof Pathology international, 2021-02, Vol.71 (2), p.155-160
issn 1320-5463
1440-1827
language eng
recordid cdi_proquest_journals_2488006679
source Wiley Online Library All Journals
subjects atypical teratoid/rhabdoid tumor (AT/RT)
Brain
Brain cancer
Brain tumors
Case reports
Chemotherapy
favorable outcome
Gene deletion
Genetic screening
Kidneys
late onset
Nephrectomy
Peripheral blood
Radiation therapy
rhabdoid tumor of the kidney (RTK)
rhabdoid tumor predisposition syndrome (RTPS)
SMARCB1
Tumor cells
Tumors
Ventricle
Ventricles (cerebral)
title Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T18%3A41%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rhabdoid%20tumor%20predisposition%20syndrome%20with%20renal%20tumor%2010%20years%20after%20brain%20tumor&rft.jtitle=Pathology%20international&rft.au=Fukushima,%20Hiroko&rft.date=2021-02&rft.volume=71&rft.issue=2&rft.spage=155&rft.epage=160&rft.pages=155-160&rft.issn=1320-5463&rft.eissn=1440-1827&rft_id=info:doi/10.1111/pin.13056&rft_dat=%3Cproquest_cross%3E2488006679%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2488006679&rft_id=info:pmid/33378586&rfr_iscdi=true